ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors

Clinical trial NCT06001255 · UNKNOWN

Trial details

NCT number: NCT06001255
Sponsor: Hansoh BioMedical R&D Company
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastasis Castration Resistant Prostate Cancer(mCRPC)

Start date: 2024-01-18
Primary completion: 2024-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.